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Abstract
Background: Although pertussis has been considered a disease of childhood, it is also recognized as an important
respiratory tract infection in adolescents and adults. However, in countries with routine vaccination against pertussis
with high coverage, pertussis is not usually taken into consideration for the etiology of prolonged cough in adults.
Previous studies in a variety of populations in developed countries have documented that pertussis is quite
common, ranging from 2.9 to 32 % of adolescents and adults with prolonged cough. The anticipation and early
recognition of this change in the epidemiology is important because the affected adolescents and adults act as
reservoirs of the disease and source of infection to the vulnerable population of infants, for whom the disease can
be life threatening. We conducted a prospective study to determine the prevalence of pertussis in Thai adults with
prolonged cough.
Methods: Seventy-six adult patients with a cough lasting for more than 2 weeks (range, 14–180 days) were
included in the present study. The data regarding medical history and physical examination were carefully analyzed.
Nasopharyngeal swabs from all patients were obtained for the detection of deoxyribonucleic acid of Bordetella
pertussis by the polymerase chain reaction (PCR) method. Paired serum samples were collected and tested for IgG
antibody against pertussis toxin by using an ELISA method.
Results: Of 76 adult patients, 14 patients (18.4 %) with the mean age of 59 (range, 28–85) years and the mean
duration of cough of 34 (range, 14–120) days had laboratory evidence of acute pertussis infection. One patient was
diagnosed by the PCR method, while the rest had serological diagnosis. Whooping cough is a significantly
associated symptom of patients with chronic cough who had laboratory evidence of pertussis. (p < .05, odds ratio
3.75, 95 % confidence interval: 1.00,14.06)
Conclusion: Pertussis is being increasingly recognized as a cause of prolonged, distressing cough among adults in
Thailand. This result addresses the need of pertussis vaccination in Thai adults for preventing transmission to a high
risk group such as newborn infants.
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Background
Pertussis is a highly communicable, vaccine-preventable
respiratory disease caused by Bordetella pertussis, a fas-
tidious Gram-negative coccobacillus with many viru-
lence factors notable for their roles in adhesion of the
bacteria to ciliated respiratory epithelium and disrupting
the normal functions of ciliated epithelial cells [1]. In the
present vaccine era, the overall incidence of pertussis
has been reduced dramatically [2–4]. Despite high vac-
cination coverage, pertussis continues to be a major
cause of morbidity and mortality in both developed and
less developed countries. Although pertussis has trad-
itionally been considered a disease of infants and child-
hood, it was well-documented in adults nearly a century
ago [5–7]. During the past 15 years, previous reports
have shown that the incidence of pertussis in adolescents
and adults have been increasing in western countries [8,
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9]. However, the shift towards an increase in pertussis
incidence among adults that has been reported in some
countries may be a true increase but this should be
interpreted with caution owing to the much advanced
development in diagnosis and the increased awareness
of the disease. Most adult patients with acute pertussis
infection present with prolonged non-specific cough,
which most often go unrecognized by caring physicians
[10]. The increased prevalence of pertussis in adults is
probably due to the waning of the immunity against B.
pertussis, which can be obtained from a natural infection
or from childhood vaccination [11]. The immunity stim-
ulated by whole-cell vaccine and acellular vaccine can
remain in the body for about 6–8 years and 4–6 years or
longer, respectively [12, 13]. In Thailand, the pertussis
cases have continuously declined since 1977 after the
implementation of Diphtheria-Tetanus-Pertussis (DTP)
vaccine in the Expanded Program for Immunization
(EPI). Although the number of pertussis cases per
100,000 persons has dropped from 7.25 cases in 1977 to
0.02 cases in 2007, there are some outbreaks of this dis-
ease in Thailand [14].
Although several previous studies in developed coun-
tries have shown that pertussis is one of the most com-
mon causes of prolonged cough illnesses in adults,
ranging from 2.9 to 32 %, most physicians are often un-
aware of this disease [15–20]. Unrecognized infected
adults may spread this organism to the nonimmune in-
dividuals, and the infection in some high-risk groups in-
cluding young children can be more severe and
potentially fatal. In Thailand, the diagnosis of pertussis
in adults is often difficult and delayed because of a lack
of classic symptoms and/ or low physicians' awareness,
as well as unavailable laboratory diagnosis of pertussis
such as culture isolation and polymerase chain reaction
(PCR) test. Prolonged cough in many patients might be
resolved without a clear diagnosis. Consequently, they
have risk to spread the disease to a high risk group such
as infants younger than 6 months. Although a cluster of
pertussis cases were reported in Thailand, the prevalence
of pertussis in adults with prolonged cough has never
been documented [21, 22] Thus, this prospective study
was carried out to determine the prevalence of pertussis
in Thai adolescents and adults with prolonged cough.
Methods
Adult patients with age of ≥ 15 years who had a cough
for more than 2 weeks were recruited at King Chula-
longkorn Memorial Hospital (KCMH), Bangkok,
Thailand, from October 2010 to February 2011. All the
data regarding the symptoms/signs of the present illness,
history of vaccination, complications and medical treat-
ment were recorded. Chest X-ray was performed for
each patient. Patients were excluded if they were
immunocompromised, had chronic airway diseases or
other known chronic cough illness, had received medica-
tions that can cause a cough such as angiotensin-
converting enzyme inhibitors, or abnormal chest X-ray.
The study protocol was approved by the Ethical Com-
mittee of the Faculty of Medicine, Chulalongkorn Uni-
versity, Bangkok, Thailand. The written Informed
consent was obtained from each patient after the nature
of study protocol had been fully explained. For the chil-
dren under the age of 18, the parent or guardian of the
child had provided informed consent on behalf of the
child.
Specimen collection for B. pertussis
Nasopharyngeal swab was obtained from each patient by
using rayon-tipped swabs on aluminum shafts. B. pertus-
sis DNA was detected in nasopharyngeal swab speci-
mens by the real-time PCR method that amplified the
specific genome of target bacteria. Specific primer of tar-
get region of B. pertussis is the upstream region of por
gene. The result is interpreted by a gel electrophoresis
technique, melting temperature (Tm), or threshold cycle
(Ct) of PCR product. The real-time PCR of SYBR green
is interpreted by comparing with positive and negative
control. The sequences of these 2 primers were BP-B3
(5’-GGG AAG TTG ACG CTA TTG CA-3’) and BP-BF
(5’-ATC GGG CAT GCT TAT GGG TGT TCA-3’). The
amplicon was 260 bp in size. The bacteria that was used
to standardize these PCR tests was Escherichia coli
DMST 26008 (containing plasmid pBORDET to positive
control for B. pertussis) or B. pertussis DMST 19589.
Blood samples were obtained for determination of IgG
antibody by using Bordetella PT IgG ELISA test (IBL kit;
IBL international GMBH, Germany) on day of enroll-
ment and 2 weeks later.
Pertussis case definition
A patient was considered to have definite laboratory-
confirmed B. pertussis infection if the PCR test of naso-
pharyngeal swab specimen was positive for B. pertussis
[23]. The four-fold rising in acute and convalescent
phase of serum samples (paired sera) or the agglutinin
titer of ≥ 3 SD (single serum) of Bordetella PT IgG was
considered as acute probable pertussis infection. All pa-
tients must not have evidence of Chlamydophila pneu-
moniae and Mycoplasma pneumoniae infection as
negative results of polymerase chain reaction of the re-
spiratory specimens.
Statistical analysis
Frequency and percentage were used for analysis of the
prevalence of pertussis in our patients with chronic
cough. A Chi-squared test and Fisher’s exact test were
used to compare the frequencies between the groups.
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Student t-test and Mann Whiney U test were used to
compare continuous variables between the groups.
Results
Seventy-six patients (age range 15–87 years) with pro-
longed cough (range 14–180 days) were enrolled. Four-
teen patients (18.4 %) had laboratory evidence of
pertussis. One patient was diagnosed by the PCR
method, compatible with definite pertussis, while 13 pa-
tients had probable pertussis (Table 1). For the group of
patients who had the laboratory evidence of pertussis,
the age was 59 ± 16.45 years (range 28–85 years) and the
duration of cough was 34.07 ± 31.52 days (range 14–120
days). Before enrollment into the present study, most of
these patients were diagnosed with allergies and bron-
chitis. Interestingly, the whooping cough is the statisti-
cally significant associated symptom of patients who had
laboratory evidence of pertussis (p < .05, odds ratio 3.75,
95%confidence interval 1.00–14.06). Concerning the age
of the patients, it was evident that there was a high per-
centage of those who were 65 years and more (35.3 % of
the first group and 29.0 % of the second respectively).
None of our patients had ever received a boosted acellu-
lar pertussis vaccine (Table 1).
Discussion
There are a wide variety of diagnoses in patients with
prolonged cough including the infectious cause. This
pertussis-like syndrome can be caused by several viruses
including adenovirus, influenza virus, parainfluenza vi-
ruses, and respiratory syncytial virus or bacteria includ-
ing Chlamydophila pneumoniae or Mycoplasma
pneumoniae [24]. The detection of pertussis in adoles-
cents and adults with chronic cough has been found to
be very important since the disease can transmit to in-
fants who have no immunity to pertussis resulting in a
higher mortality rate. The incidence of pertussis in
adults with prolonged cough increased due to the de-
clined level of immunity against B.pertussis, obtained
from a childhood vaccination or natural infection. Des-
pite high vaccine coverage in infants and children, there
are resurgences of pertussis in adolescents and adults in
many western countries [3, 15, 16]. Previous studies have
shown that the prevalence of B. pertussis infection in ad-
olescents and adults with prolonged cough of more than
1–3 weeks was 2.9 % to 32 % in developed countries
[15–20]. This difference is partly because each study has
different criteria of the cough duration which can range
from 7 to 21 days and the laboratory diagnosis of pertus-
sis in each study was different. Laboratory diagnostic
tests for B.pertussis infection include the culture of the
properly obtained nasopharyngeal specimen, the PCR
test, and the test for serum antibodies by using enzyme-
linked immunosorbent assays (ELISA) or Western blot.
The present study showed that only 1.3 % of Thai adults
with prolonged cough had laboratory-confirmed of B.
pertussis infection. This is not surprising since the sensi-
tivity to detect pertussis infection is low and depends on
the timing of specimen collection. The PCR test for
diagnosis of pertussis has very high sensitivity during the
first 3 weeks of cough when bacterial DNA is still
present in the nasopharynx [25–27]. In the present
study, all patients had had cough of more than 2 weeks,
and the mean duration of cough in pertussis patients
was 30 days (range 14–120), and this might be too long
to detect by using the PCR test.
When a variety of tests including culture, PCR and
serology tests are combined in the diagnosis of pertussis
in adults, the results may yield a higher prevalence of
the disease. Culture of B.pertussis from nasopharyngeal
swab has shown a high specificity but the sensitivity in
the detection of this organism is relatively low. Serologic
testing is frequently used for epidemiologic or research
purposes, but it is neither widely available nor standard-
ized. The detection of specific antibody against pertussis
toxin is a well-known test for its ability to detect the
good immune response after B. pertussis infection. PT
IgG ELISA test is also commonly used in the diagnosis.
Compared to the other methods, PT IgG ELISA test is
also commonly used in many studies for the diagnosis of
B. pertussis infection in adults with prolonged cough re-
garding the sensitivity and specificity, however, there is
no standardization in the interpretation until recently
[28]. In the present study, when PCR and serology tests
were employed for the diagnosis of pertussis infection,
18.4 % of patients with prolonged cough had evidence of
acute infection of pertussis. This seems to be high, com-
pared to the previous studies [17–20].
Undiagnosed infected adults may spread the organism
to the nonimmune individuals, and the infection in some
high-risk groups including young children can be more se-
vere and potentially fatal. Thus, the awareness of pertussis
in adolescents and adults with prolonged cough should be
emphasized as one of the public health problems in
Thailand where pertussis vaccine (combined with diph-
theria toxoid and tetanus toxoid) has been part of EPI in
childhood period. Antibiotic therapy such as macrolides
or cotrimoxazole during the early catarrhal phase may
eradicate the organism from patients’ nasopharynx, the
definite diagnosis of pertussis is rarely considered at the
time before initiating antibiotic treatment in prolonged
cough in adolescents and adults [29]. However, Increasing
clinician awareness and reporting of pertussis in patients
who have prolonged cough illnesses with the use of more
sensitive diagnostic techniques (especially PCR testing)
may be the important management for this diseases in
Thailand. The national vaccination program in Thailand
must be emphasized as the role of routine pertussis
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Table 1 Clinical characteristics and laboratory findings of patients with prolonged cough with or without laboratory evidence of pertussis
Patients with
laboratory evidence of
pertussis (n = 14)
Patients without
laboratory evidence of
pertussis (n = 62)
P value Odd Ratio 95 % CI
Age : mean ± SD 59 ± 16.45 years 54.16 ± 16.66 years 0.33 - 4.96,14.64
(range) (28–85) (15–87)
age group 15–25 years 0 3(4.83 %)
age group 26–45 years 3(21.4 %) 18(29.03 %)
age group 46–65 years 6(48.6 %) 33(53.23 %)
age group >65 years 5(35.7 %) 18(29.03 %0
Male : female ratio 5:9 23:39 0.92 0.94 0.28,3.16
History of Tdap vaccination 0 0
Duration of cough:
mean ± SD 34.07 ± 31.52 days 30.03 ± 27.42 days 0.63 - -
(range) (14–120 days) (14–180 days)
Provisional diagnosis:
- allergy- gastroesophageal reflux-
bronchitis- bronchial asthma- post-
infectious cough- others and unknown
diagnosis
3 (21.4 %)1 (7.1 %)1
(7.1 %)1 (7.1 %)1
(7.1 %)7 (50 %)
17 (27.4 %)2 (3.2 %)20
(32.3 %)2 (3.2 %)4
(6.5 %)17(27.4 %)
Associated symptoms:
- weight loss- hoarseness- headache-
sleep disturbance- whooping cough-
Influenza-like symptoms- sneezing
attack
3 (21.4 %)6 (42.9 %)3
(21.4 %)3 (21.4 %)5
(35.7 %)4 (28.6 %)4
(28.6 %)
11 (17.7 %)32 (51.6 %)16
(25.8 %)15 (24.2 %)8







rib fracture- pneumothorax- inguinal
hernia- seizure- otitis media or hearing
loss
11 (78.6 %)1
(7.1 %)00002 (14.3 %)
49 (79 %)11 (17.7 %)01
(1.6 %)001 (1.6 %)













vaccination in adolescents and adults as well as in infants
and children to create the herd immunity in the popula-
tion. Because recent studies have shown that the protec-
tion from pertussis vaccines given in childhood wanes
substantially over time, tetanus-diphtheria-acellular per-
tussis (Tdap) vaccine should be actively provided for ado-
lescents and adults especially with pregnancy, healthcare
personnel and any persons who have close contact with
infants of less than 12 months of age in many countries
including Thailand [30].
This study was performed in a tertiary care center in
the capital city of Thailand in limited period of time.
This result might not represent the prevalence of pertus-
sis in other regions in the country. Further research
should extend to other regions in to identify the cause of
prolonged cough in Thai adults and adolescent.
Conclusion
In conclusion, the prevalence of pertussis has increased
in adolescents and adults with prolonged cough in many
countries. Pertussis also is being increasingly recognized
as a cause of prolonged, distressing cough among adults
in Thailand. The results of the present study address the
need of good surveillance system and better
immunization program in Thai adolescents and adults
to prevent the transmission of this disease to high risk
groups; such as newborn infants.
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